Theriva Biologics (TOVX) Q4 2025 Earnings

12NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-7.22
-2.8
1.61
6.03

Details

Expected EPS
-0.38
Actual EPS
-0.45
Surprise EPS
-0.07
Surprise Percent
+18.42%

Description

Theriva Biologics (TOVX) has reported earnings of -0.45 per share for Q4 2025.

0 Comments

Share your thoughts